Dabur India Ltd vs Mukka Proteins Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 22, 2026

Key Highlights

The Latest Trading Price of Dabur India Ltd is ₹ 388.5 as of 21 Sep 15:30 . The P/E Ratio of Dabur India Ltd changed from 56.4 on March 2021 to 38.4 on March 2026 . This represents a CAGR of -6.21% over 6 yearsThe P/E Ratio of Mukka Proteins Ltd changed from 15.6 on March 2024 to 10.6 on March 2026 . This represents a CAGR of -12.09% over 3 years The Market Cap of Dabur India Ltd changed from ₹ 95564 crore on March 2021 to ₹ 72792 crore on March 2026 . This represents a CAGR of -4.44% over 6 yearsThe Market Cap of Mukka Proteins Ltd changed from ₹ 1094 crore on March 2024 to ₹ 551.7 crore on March 2026 . This represents a CAGR of -20.41% over 3 years The revenue of Dabur India Ltd for the Jun '26 is ₹ 3936 crore as compare to the Mar '26 revenue of ₹ 3213 crore. This represent the growth of 22.53% The revenue of Mukka Proteins Ltd for the Jun '26 is ₹ 491.25 crore as compare to the Mar '26 revenue of ₹ 395.92 crore. This represent the growth of 24.08% The ebitda of Dabur India Ltd for the Jun '26 is ₹ 913.45 crore as compare to the Mar '26 ebitda of ₹ 635.85 crore. This represent the growth of 43.66% The ebitda of Mukka Proteins Ltd for the Jun '26 is ₹ 48.62 crore as compare to the Mar '26 ebitda of ₹ 49.18 crore. This represent the decline of -1.14% The net profit of Dabur India Ltd changed from ₹ 494.35 crore to ₹ 586.16 crore over 9 quarters. This represents a CAGR of 7.87% The net profit of Mukka Proteins Ltd changed from ₹ 5.26 crore to ₹ 18.63 crore over 9 quarters. This represents a CAGR of 75.43% The Dividend Payout of Dabur India Ltd changed from 60.75 % on March 2021 to 98.13 % on March 2026 . This represents a CAGR of 8.32% over 6 yearsThe Dividend Payout of Mukka Proteins Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dabur India Ltd

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products.
The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods.
Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products. The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD).
Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods.

About Mukka Proteins Ltd

Mukka Proteins Limited was originally incorporated as 'Mukka Sea Food Industries', a Partnership firm in Karnataka on March 13, 2003.
Subsequently, the Partnership Firm was thereafter converted to Private Company as 'Mukka Sea Food Industries Private Limited' on November 04, 2010.
The Company subsequently got converted into Public Limited Company dated December 02, 2019 in the name of 'Mukka Sea Food Industries Limited' and the name of the Company changed to 'Mukka Proteins Limited' vide a fresh certificate of incorporation issued by ROC-Bangalore, dated August 06, 2021. The Company manufacture fish meal, fish oil and fish soluble paste, an essential ingredient in the manufacturing of aqua feed (for fish and shrimp), poultry feed (for broiler and layer) and pet food (dog and cat food).
Further, fish oil also finds its application in pharmaceutical products (additionally, the EPA-DHA extraction is used as an ingredient in nutraceuticals), soap manufacturing, leather tanneries & paint industries.

FAQs for the comparison of Dabur India Ltd and Mukka Proteins Ltd

Which company has a larger market capitalization, Dabur India Ltd or Mukka Proteins Ltd?

Market cap of Dabur India Ltd is 68,918 Cr while Market cap of Mukka Proteins Ltd is 844 Cr

What are the key factors driving the stock performance of Dabur India Ltd and Mukka Proteins Ltd?

The stock performance of Dabur India Ltd and Mukka Proteins Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dabur India Ltd and Mukka Proteins Ltd?

As of September 22, 2026, the Dabur India Ltd stock price is INR ₹388.5. On the other hand, Mukka Proteins Ltd stock price is INR ₹28.15.

How do dividend payouts of Dabur India Ltd and Mukka Proteins Ltd compare?

To compare the dividend payouts of Dabur India Ltd and Mukka Proteins Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.